PT - JOURNAL ARTICLE AU - Mhmoud, Najwa A TI - Molecular identification of species of family Chaetomiaceae (Sordariomycetes, Ascomycota) from soil, dung and water in Sudan AID - 10.1101/2022.04.05.22273477 DP - 2022 Jan 01 TA - medRxiv PG - 2022.04.05.22273477 4099 - http://medrxiv.org/content/early/2022/04/10/2022.04.05.22273477.short 4100 - http://medrxiv.org/content/early/2022/04/10/2022.04.05.22273477.full AB - Species of Chaetomiaceae family are ubiquitous filamentous fungi, that responsible for a wide range of opportunistic human infections. To date, it encompasses more than 300 species have been described in genus Chaetomium. It have been globally reported as being are capable of colonizing various substrates. Due to the lack of genetic studies on the species belonging to this genus in Sudan, This work aimed to investigate the environmental fungal occurrence within the family Chaetomiaceae by using morphological characters and molecular sequencing.A total of 260 environmental samples from soil, animal dung and water were collected from six different states in Sudan in two ecozones: .desert or semis desert ecozones (Dongola in Northern sudan, El-Obeid in western sudan); a low rainfall woodland savanna ecozone (Gazira, El Geteina and Khartoum from central Sudan and AlQadarif in eastern Sudan).During a study of environmental fungi in Sudan, 119 isolates were identified as members of Chaetomiaceae after the ITS sequencing combined with an examination of the macro- and micromorphology. Out of 63 Chaetomium strains obtained from soil, animal dung and water samples, 25 were obtained from soil, 22 from animal dung and 16 from water. 56 additional strains isolated from other genus within the Chaetomiaceae family, such as (Amesia, Collariella, Ovatospora, Subramaniula and Thielavia) were recorded for the first time in Sudan.In conclusion: Sequence-based identification of fungal isolates is often considered to be the most reliable and accurate identification method.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors(rDNA)The ribosomal DNAITSinternal transcribed spacer geneBT2the first β-tubulin locusTUBthe second β-tubulin locusACT1partial sequences of the actinRPB1DNA-dependent RNA polymerase II largest subunitRPB2second largest subunitTEF1.elongation factor 1α genes